BioWorld

Feb. 13, 2006

View Archived Issues

Acorda’s Second Attempt At IPO Successful: $33M

Acorda Therapeutics Inc. priced a $33 million initial public offering Friday, selling 5.5 million common shares at $6 apiece. (BioWorld Today) Read More

Private Placement Adding $27M To VaxGen’s Anthrax Drug Work

Read More

Deal Terms Reward Products: No Surprise From 2005 Trends

Read More

Black Box Warning Labels To Remain On All NSAIDs

Read More

After First Product Approval, BioMimetic Seeks $50M IPO

Read More

Clinic Roundup

Read More

Other News To Note

Read More